Search

Free Shipping On All Orders Over $100
GET 20% OFF WHEN YOU SPEND $500 OR MORE

In Stock

Buy Taltz (ixekizumab) Online

4 Reviews

DISEASE INDICATIONS: Psoriasis

MANUFACTURER: Eli Lilly Nederland B.V.

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

From $2,499.58

Clear

Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Uses

Taltz is used to treat:

  • Moderate to severe plaque psoriasis
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Non-radiographic axial spondyloarthritis

Storage Conditions

Taltz should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze. Taltz can be kept at room temperature for up to 24 hours.

Mechanism of Action

Taltz is a monoclonal antibody that binds to IL-17A and blocks its interaction with the IL-17 receptor. IL-17A is a cytokine that plays a key role in the development and progression of inflammatory diseases such as psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. By blocking IL-17A, Taltz can help to reduce inflammation and improve the symptoms of these diseases.

How to Use

Taltz is administered by subcutaneous injection every 4 or 12 weeks, depending on the condition being treated. The recommended dose is 80 mg. Taltz can be self-injected or injected by a healthcare professional.

Important Safety Information

Taltz can increase the risk of serious infections, including tuberculosis. Before starting Taltz, your doctor will test you for tuberculosis. Taltz can also reactivate latent tuberculosis infection.

Taltz can also increase the risk of other side effects, such as:

  • Allergic reactions
  • Inflammatory bowel disease (IBD)
  • Psoriasis worsening
  • Injection site reactions
  • Upper respiratory tract infections
  • Headache
  • Diarrhea
  • Nausea
  • Fatigue

Indications

Taltz is indicated for the treatment of adults with:

  • Moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy
  • Active psoriatic arthritis
  • Active ankylosing spondylitis
  • Active non-radiographic axial spondyloarthritis with objective signs of inflammation

Precautions

Taltz should be used with caution in patients with a history of serious infections, tuberculosis, IBD, or other autoimmune diseases.

Taltz should not be used in patients who have a history of severe allergic reactions to Taltz or other biologic medications.

Interactions

Taltz may interact with other medications, including live vaccines and biologic medications. Be sure to tell your doctor about all of the medications you are taking before starting Taltz.

Contraindications

Taltz is contraindicated in patients with a history of severe allergic reactions to Taltz or other biologic medications.

Overdose

There is no known overdose of Taltz.

Side Effects

The most common side effects of Taltz are upper respiratory tract infections, headache, diarrhea, nausea, fatigue, and injection site reactions.

More serious side effects of Taltz include serious infections, IBD, psoriasis worsening, and allergic reactions.

If you experience any side effects while taking Taltz, be sure to tell your doctor.

Conclusion

Taltz is a safe and effective treatment for moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is important to talk to your doctor about the risks and benefits of Taltz before starting treatment.

Package

2 prefilled syringes or pens of 80 mg, 3 prefilled syringes or pens of 80 mg

Latest reviews

  1. dfoster_dermlife

    I’ve been on Taltz for nearly a year now, and it continues to deliver consistent results. My psoriasis plaques have diminished, and my overall quality of life has improved. The medication is easy to administer and fits well into my routine.

  2. Laura Simmons

    Taltz has improved both my joint symptoms and skin condition dramatically. It’s helped reduce inflammation and flare-ups without any serious side effects. The injection pen is convenient, and the support from my healthcare team has been excellent.

  3. mreynolds_activehealth

    I started Taltz under my dermatologist’s care, and the results were noticeable much faster than I expected. My skin cleared up, and the joint pain associated with psoriatic arthritis has decreased substantially. Easy to use and very reliable.

  4. Jessica Collins

    Taltz has been a breakthrough in managing my psoriasis. After months of struggling with flare-ups, this medication cleared my skin significantly within weeks. The injections are straightforward, and I’ve experienced minimal side effects. Highly recommend for anyone with moderate to severe psoriasis.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Adbry (tralokinumab-ldrm) Online

$1,283.00
(3 Reviews)
DISEASE INDICATIONS: Atopic Dermatitis MANUFACTURER: Leo Pharma USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Adbry (tralokinumab-ldrm) is a fully human monoclonal antibody that neutralizes the activity of interleukin-13 (IL-13), a cytokine that plays a key role in the pathogenesis of atopic dermatitis. Adbry is approved for the treatment of moderate-to-severe atopic dermatitis (AD) in adults and adolescents 12 years of age and older.

Buy Tremfya (guselkumab) Online

$2,860.64
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Janssen Biotech USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Buy Zoryve (roflumilast) Online

$1,026.40
(3 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Arcutis Biotherapeutics, Inc. USAGE: Cutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Zoryve (roflumilast) is a topical cream used to treat plaque psoriasis in adults and children 12 years of age and older. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.

Buy Rinvoq (upadacitinib) Online

$1,955.31
(0 Reviews)
Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

Buy Ilumya (tildrakizumab) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Almirall, S.A. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ilumya (tildrakizumab) is a prescription medication used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the p19 subunit of interleukin-23 (IL-23), a cytokine that plays a key role in the development and progression of psoriasis.

Buy Taltz (ixekizumab) Online

From $2,499.58
(4 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Buy Spevigo (spesolimab-sbzo) Online

(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Boehringer Ingelheim USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Spevigo (spesolimab-sbzo) is a prescription medication used to treat generalized pustular psoriasis (GPP) flares in adults. GPP is a rare autoinflammatory skin disease that can cause painful pustules (blisters) to form all over the body. Spevigo is the first FDA-approved treatment for GPP flares.

Back to Top
Product has been added to your cart